Boundless Bio, Inc. (BOLD) › Capital ExpendituresBoundless Bio, Inc. (BOLD) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2023: $633.0K2024: $2.54M2025: $546.0K$546.0K2023Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$546.0K-78.5%2024$2.54M+300.6%2023$633.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share